Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 1:40 pm Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Samlyn Capital, LLC | 3,372,558 5.500% | 3,372,558 (New Position) | Filing History |
| 2024-02-14 1:31 pm Purchase | 2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Samlyn Capital, LLC | 2,496,259 5.100% | 2,496,259 (New Position) | Filing History |
| 2024-01-05 5:00 pm Purchase | 2024-01-01 | 13D | Applied Minerals, Inc. AMNL | Samlyn Capital, LLC | 85,144,328 17.800% | 6,017,588 (+7.60%) | Filing History |
| 2023-02-14 2:22 pm Sale | 2022-12-31 | 13G | Climb Bio, Inc. CLYM | Samlyn Capital, LLC | 0 0.000% | -2,128,202 (Position Closed) | Filing History |
| 2023-02-14 1:47 pm Sale | 2022-12-31 | 13G | Glass Houses Acquisition Corp. GLHA | Samlyn Capital, LLC | 0 0.000% | -1,260,198 (Position Closed) | Filing History |
| 2023-02-14 1:46 pm Sale | 2022-12-31 | 13G | Perella Weinberg Partners PWP | Samlyn Capital, LLC | 0 0.000% | -2,993,365 (Position Closed) | Filing History |
| 2023-02-14 1:45 pm Purchase | 2022-12-31 | 13G | PureCycle Technologies, Inc. PCT | Samlyn Capital, LLC | 11,544,670 6.900% | 11,544,670 (New Position) | Filing History |
| 2023-02-14 1:44 pm Purchase | 2022-12-31 | 13G | Vinci Compass Investments Ltd. VINP | Samlyn Capital, LLC | 2,381,887 5.700% | 2,381,887 (New Position) | Filing History |
| 2023-02-14 1:43 pm Sale | 2022-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Samlyn Capital, LLC | 0 0.000% | -2,570,292 (Position Closed) | Filing History |
| 2023-01-11 10:33 am Purchase | 2022-04-18 | 13D | Applied Minerals, Inc. AMNL | Samlyn Capital, LLC | 79,126,740 16.800% | 28,237,104 (+55.49%) | Filing History |
| 2022-04-04 5:12 pm Purchase | 2022-03-23 | 13G | Climb Bio, Inc. CLYM | Samlyn Capital, LLC | 2,128,202 8.000% | 424,656 (+24.93%) | Filing History |
| 2022-02-25 5:02 pm Purchase | 2022-02-15 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Samlyn Capital, LLC | 2,570,292 8.200% | 800,438 (+45.23%) | Filing History |
| 2022-02-14 2:19 pm Sale | 2021-12-31 | 13G | Sculptor Capital Management, Inc. SCU | Samlyn Capital, LLC | 0 0.000% | -1,490,084 (Position Closed) | Filing History |
| 2022-02-14 2:11 pm Purchase | 2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Samlyn Capital, LLC | 1,769,854 5.600% | 1,769,854 (New Position) | Filing History |
| 2022-02-14 2:04 pm Purchase | 2021-12-31 | 13G | Perella Weinberg Partners PWP | Samlyn Capital, LLC | 2,993,365 7.000% | 2,993,365 (New Position) | Filing History |
| 2022-02-14 1:58 pm Purchase | 2021-12-31 | 13G | Glass Houses Acquisition Corp. GLHA | Samlyn Capital, LLC | 1,260,198 5.600% | 1,260,198 (New Position) | Filing History |
| 2022-02-14 1:50 pm Sale | 2021-12-31 | 13G | Sitio Royalties Corp. STR | Samlyn Capital, LLC | 0 0.000% | -1,189,635 (Position Closed) | Filing History |
| 2022-02-14 1:42 pm Purchase | 2021-12-31 | 13G | Climb Bio, Inc. CLYM | Samlyn Capital, LLC | 1,703,546 6.400% | 1,703,546 (New Position) | Filing History |
| 2021-02-16 1:33 pm Purchase | 2020-12-31 | 13G | Sculptor Capital Management, Inc. SCU | Samlyn Capital, LLC | 1,490,084 6.600% | 1,490,084 (New Position) | Filing History |
| 2021-02-16 1:31 pm Purchase | 2020-12-31 | 13G | Sitio Royalties Corp. STR | Samlyn Capital, LLC | 1,189,635 9.800% | 58,454 (+5.17%) | Filing History |